Financial Snapshot

Revenue
$4.076B
TTM
Gross Margin
92.96%
TTM
Net Earnings
$32.48M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
187.04%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$3.171B
Q3 2024
Cash
Q3 2024
P/E
442.6
Nov 29, 2024 EST
Free Cash Flow
$36.08M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Revenue $3.696B $3.395B $2.986B $2.667B $2.159B $1.882B $1.536B $1.106B $753.8M $511.5M $354.9M $297.1M $94.46M $169.9M $9.300M $3.900M $34.40M $27.60M $7.800M $14.10M $41.20M $95.50M $219.3M $194.2M $157.0M $134.8M $90.00M $41.90M $12.20M $200.0K $300.0K $1.600M
YoY Change 8.87% 13.67% 11.98% 23.53% 14.71% 22.5% 38.94% 46.68% 47.37% 44.11% 19.49% 214.5% -44.41% 1726.88% 138.46% -88.66% 24.64% 253.85% -44.68% -65.78% -56.86% -56.45% 12.92% 23.69% 16.47% 49.78% 114.8% 243.44% 6000.0% -33.33% -81.25% 433.33%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Revenue $3.696B $3.395B $2.986B $2.667B $2.159B $1.882B $1.536B $1.106B $753.8M $511.5M $354.9M $297.1M $94.46M $169.9M $9.300M $3.900M $34.40M $27.60M $7.800M $14.10M $41.20M $95.50M $219.3M $194.2M $157.0M $134.8M $90.00M $41.90M $12.20M $200.0K $300.0K $1.600M
Cost Of Revenue $255.0M $207.0M $151.0M $131.3M $114.2M $94.12M $79.48M $45.60M $27.00M $3.000M $630.0K $157.0K
Gross Profit $3.441B $3.188B $2.835B $2.535B $2.045B $1.788B $1.457B $1.060B $726.8M $508.5M $354.3M $296.9M
Gross Profit Margin 93.1% 93.9% 94.94% 95.08% 94.71% 95.0% 94.83% 95.88% 96.42% 99.41% 99.82% 99.95%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Selling, General & Admin $1.161B $1.002B $739.6M $516.9M $468.7M $434.4M $366.3M $303.3M $196.6M $165.8M $110.0M $85.36M $58.22M $32.33M $27.60M $17.10M $15.20M $14.00M $11.70M $20.60M $29.40M $45.10M $70.60M $64.20M $37.20M $25.40M $13.90M $7.000M $3.900M $1.700M $700.0K $700.0K
YoY Change 15.88% 35.5% 43.07% 10.29% 7.9% 18.6% 20.77% 54.27% 18.58% 50.75% 28.84% 46.62% 80.09% 17.13% 61.4% 12.5% 8.57% 19.66% -43.2% -29.93% -34.81% -36.12% 9.97% 72.58% 46.46% 82.73% 98.57% 79.49% 129.41% 142.86% 0.0% 75.0%
% of Gross Profit 33.75% 31.44% 26.08% 20.39% 22.93% 24.3% 25.14% 28.61% 27.05% 32.61% 31.04% 28.75%
Research & Development $1.628B $1.586B $1.458B $2.216B $1.154B $1.198B $1.326B $581.9M $479.5M $347.5M $260.4M $210.4M $178.7M $123.9M $119.4M $146.4M $104.9M $87.60M $95.60M $88.30M $111.4M $145.3M $213.3M $192.6M $146.8M $97.20M $72.50M $41.30M $19.20M $10.50M $4.500M $3.100M
YoY Change 2.63% 8.76% -34.2% 92.0% -3.66% -9.67% 127.9% 21.36% 37.99% 33.43% 23.79% 17.73% 44.26% 3.75% -18.44% 39.56% 19.75% -8.37% 8.27% -20.74% -23.33% -31.88% 10.75% 31.2% 51.03% 34.07% 75.54% 115.1% 82.86% 133.33% 45.16% 287.5%
% of Gross Profit 47.3% 49.75% 51.43% 87.4% 56.45% 67.01% 91.03% 54.89% 65.97% 68.34% 73.5% 70.86%
Depreciation & Amortization $82.66M $67.86M $57.84M $51.81M $54.53M $54.97M $52.18M $58.40M $44.90M $41.40M $29.21M $29.98M $26.99M $24.49M $16.70M $13.10M $13.00M $7.400M $8.200M $13.90M $16.90M $22.10M $46.40M $34.30M $24.70M $17.80M $10.60M $6.500M $2.800M $1.000M $400.0K $200.0K
YoY Change 21.82% 17.31% 11.65% -5.0% -0.79% 5.35% -10.65% 30.07% 8.45% 41.75% -2.58% 11.07% 10.23% 46.62% 27.48% 0.77% 75.68% -9.76% -41.01% -17.75% -23.53% -52.37% 35.28% 38.87% 38.76% 67.92% 63.08% 132.14% 180.0% 150.0% 100.0% 100.0%
% of Gross Profit 2.4% 2.13% 2.04% 2.04% 2.67% 3.07% 3.58% 5.51% 6.18% 8.14% 8.24% 10.1%
Operating Expenses $2.789B $2.588B $2.198B $2.733B $1.623B $1.632B $1.692B $897.7M $676.1M $513.3M $370.4M $295.8M $236.9M $156.2M $147.1M $163.4M $120.1M $104.5M $107.2M $163.0M $156.5M $227.8M $414.3M $256.8M $184.1M $122.7M $86.40M $48.30M $23.10M $12.30M $5.200M $3.800M
YoY Change 7.76% 17.76% -19.58% 68.4% -0.58% -3.55% 88.53% 32.78% 31.72% 38.57% 25.25% 24.83% 51.67% 6.19% -9.98% 36.05% 14.93% -2.52% -34.23% 4.15% -31.3% -45.02% 61.33% 39.49% 50.04% 42.01% 78.88% 109.09% 87.8% 136.54% 36.84% 245.45%
Operating Profit $620.5M $579.4M $585.8M -$263.7M $402.0M $129.2M -$243.4M $162.4M $50.70M -$4.800M -$16.10M $1.148M -$143.2M $14.05M
YoY Change 7.09% -1.08% -322.16% -165.59% 211.09% -153.09% -249.87% 220.32% -1156.25% -70.19% -1502.61% -100.8% -1119.17%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Interest Expense $2.551M $2.666M $1.908M $2.174M $1.855M $1.543M $6.900M -$37.60M -$43.10M -$43.50M $38.65M $46.06M $43.82M $43.32M -$32.10M -$19.60M -$1.600M $2.800M -$3.500M -$13.70M -$17.50M -$400.0K $13.30M $29.90M -$500.0K $5.800M $3.800M $2.300M $1.000M $500.0K $100.0K $0.00
YoY Change -4.31% 39.73% -12.24% 17.2% 20.22% -77.64% -118.35% -12.76% -0.92% -212.54% -16.08% 5.11% 1.14% -234.96% 63.78% 1125.0% -157.14% -180.0% -74.45% -21.71% 4275.0% -103.01% -55.52% -6080.0% -108.62% 52.63% 65.22% 130.0% 100.0% 400.0% -100.0%
% of Operating Profit 0.41% 0.46% 0.33% 0.46% 1.19% -23.15% -85.01% 4012.02% 308.37%
Other Income/Expense, Net $172.3M $39.93M $10.65M $23.21M $52.18M $31.76M $17.15M $0.00 -$300.0K -$11.50M $0.00 $0.00 $0.00 -$100.0K -$500.0K $200.0K -$1.800M $600.0K $0.00 $0.00
YoY Change 331.6% 275.05% -54.12% -55.53% 64.3% 85.16% -100.0% -97.39% -100.0% -80.0% -350.0% -111.11% -400.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Pretax Income $834.2M $529.1M $570.4M -$232.2M $486.8M $115.3M -$312.3M $107.4M $7.600M -$48.50M -$82.85M -$44.15M -$186.5M -$31.85M -$211.9M -$178.9M -$86.90M -$74.20M -$103.9M -$163.2M -$166.0M -$132.9M -$184.6M -$29.50M -$27.60M $5.800M $7.500M -$7.300M -$9.900M -$11.50M -$4.900M -$2.100M
YoY Change 57.66% -7.24% -345.65% -147.7% 322.02% -136.94% -390.77% 1313.16% -115.67% -41.46% 87.67% -76.33% 485.76% -84.97% 18.45% 105.87% 17.12% -28.59% -36.34% -1.69% 24.91% -28.01% 525.76% 6.88% -575.86% -22.67% -202.74% -26.26% -13.91% 134.69% 133.33% 40.0%
Income Tax $236.6M $188.5M -$378.1M $63.48M $39.89M $5.854M $852.0K $3.200M $1.000M -$100.0K $299.0K $174.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$600.0K $500.0K $300.0K $900.0K $900.0K $200.0K -$800.0K $2.400M $500.0K $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 28.36% 35.62% -66.29% 8.19% 5.08% 2.98% 13.16% 41.38% 6.67%
Net Earnings $597.6M $340.7M $948.6M -$295.7M $446.9M $109.5M -$313.1M $104.2M $6.500M -$48.50M -$83.10M -$44.30M -$186.5M -$31.80M -$211.9M -$178.9M -$86.90M -$74.20M -$103.0M -$164.8M -$166.5M -$136.9M -$183.2M -$29.70M -$26.80M $3.500M $6.900M -$7.300M -$9.900M -$11.50M -$4.900M -$2.100M
YoY Change 75.42% -64.09% -420.79% -166.17% 308.16% -134.97% -400.52% 1503.08% -113.4% -41.64% 87.58% -76.25% 486.48% -84.99% 18.45% 105.87% 17.12% -27.96% -37.5% -1.02% 21.62% -25.27% 516.84% 10.82% -865.71% -49.28% -194.52% -26.26% -13.91% 134.69% 133.33% 40.0%
Net Earnings / Revenue 16.17% 10.04% 31.76% -11.09% 20.7% 5.82% -20.38% 9.42% 0.86% -9.48% -23.41% -14.91% -197.45% -18.72% -2278.49% -4587.18% -252.62% -268.84% -1320.51% -1168.79% -404.13% -143.35% -83.54% -15.29% -17.07% 2.6% 7.67% -17.42% -81.15% -5750.0% -1633.33% -131.25%
Basic Earnings Per Share $2.67 $1.53 $4.30 -$1.36 $2.08 $0.52 -$1.53
Diluted Earnings Per Share $2.65 $1.52 $4.27 -$1.36 $2.05 $0.51 -$1.53 $536.8K $34.70K -$288.9K -$560.0K -$341.6K -$1.487M -$261.5K -$2.059M -$1.992M -$1.032M -$885.4K -$1.236M -$2.209M -$2.332M -$2.031M -$2.767M -$469.9K -$476.0K $60.55K $130.2K -$162.9K -$263.3K -$409.3K -$753.8K -$265.8K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Cash & Short-Term Investments $3.656B $3.239B $2.348B $1.801B $2.118B $1.438B $1.170B $808.5M $707.8M $600.3M $509.0M $228.4M $277.6M $424.2M $470.4M $198.0M $256.4M $318.6M $345.0M $469.8M $293.8M $429.0M $507.9M $582.2M $66.90M $111.2M $113.1M $38.30M $41.20M $25.20M $15.50M $5.500M
YoY Change 12.88% 37.93% 30.35% -14.93% 47.23% 22.97% 44.66% 14.23% 17.91% 17.94% 122.85% -17.72% -34.56% -9.82% 137.58% -22.78% -19.52% -7.65% -26.56% 59.9% -31.52% -15.53% -12.76% 770.25% -39.84% -1.68% 195.3% -7.04% 63.49% 62.58% 181.82%
Cash & Equivalents $3.656B $2.951B $2.057B $1.513B $1.833B $1.164B $899.5M $652.3M $521.4M $452.3M $471.4M $224.1M $273.2M $417.9M $449.8M $178.8M $108.9M $18.90M $11.50M $132.2M $29.70M $22.90M $43.40M $110.2M $32.20M $50.00M $55.60M $7.600M $10.50M $6.800M $15.50M $4.800M
Short-Term Investments $442.7M $287.5M $290.8M $288.4M $284.9M $274.3M $270.1M $156.2M $186.3M $148.0M $37.60M $4.400M $4.400M $6.300M $20.60M $19.30M $147.6M $299.7M $333.5M $337.6M $264.1M $406.1M $464.5M $472.0M $34.70M $61.20M $57.50M $30.60M $30.60M $18.30M $0.00 $700.0K
Other Short-Term Assets $182.8M $167.0M $126.3M $60.10M $43.70M $79.40M $62.40M $32.80M $18.30M $21.00M $11.00M $9.900M $26.80M $25.60M $21.90M $6.400M $6.400M $7.100M $7.600M $9.400M $11.90M $21.30M $29.30M $30.70M $16.00M $5.800M $9.800M $2.800M $800.0K $200.0K $200.0K $0.00
YoY Change 9.47% 32.26% 110.11% 37.53% -44.96% 27.24% 90.24% 79.23% -12.86% 90.91% 11.11% -63.06% 4.69% 16.89% 242.19% 0.0% -9.86% -6.58% -19.15% -21.01% -44.13% -27.3% -4.56% 91.88% 175.86% -40.82% 250.0% 250.0% 300.0% 0.0%
Inventory $62.97M $42.00M $27.90M $16.40M $11.40M $7.000M $6.500M $4.100M $1.800M $400.0K $400.0K $300.0K $0.00
Prepaid Expenses
Receivables $743.6M $644.9M $616.3M $481.8M $308.4M $306.9M $264.7M $148.8M $114.5M $57.90M $35.40M $71.00M $6.400M $5.700M $163.7M $1.100M $1.600M $2.100M $1.400M $2.100M $5.200M $8.500M $54.00M $35.00M $26.60M $14.30M $20.00M $2.100M $7.600M $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00 $200.0K $400.0K $700.0K $1.600M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $4.400B $4.093B $3.119B $2.360B $2.482B $1.832B $1.505B $994.2M $842.4M $679.6M $555.8M $309.5M $310.8M $455.5M $656.1M $205.5M $264.4M $327.8M $354.0M $481.3M $310.9M $458.8M $591.2M $647.9M $109.5M $131.4M $142.9M $43.20M $49.60M $25.30M $15.70M $5.500M
YoY Change 7.49% 31.24% 32.15% -4.9% 35.43% 21.76% 51.37% 18.02% 23.96% 22.27% 79.58% -0.42% -31.77% -30.57% 219.27% -22.28% -19.34% -7.4% -26.45% 54.81% -32.24% -22.4% -8.75% 491.69% -16.67% -8.05% 230.79% -12.9% 96.05% 61.15% 185.45%
Property, Plant & Equipment $777.0M $765.6M $751.5M $588.1M $406.6M $319.8M $259.8M $167.7M $86.00M $81.80M $26.80M $6.300M $6.400M $4.800M $1.800M $2.800M $3.900M $5.900M $7.700M $10.00M $27.20M $31.80M $47.90M $98.90M $67.30M $54.40M $38.10M $22.90M $9.100M $3.300M $1.900M $1.300M
YoY Change 1.49% 1.88% 27.78% 44.64% 27.14% 23.09% 54.92% 95.0% 5.13% 205.22% 325.4% -1.56% 33.33% 166.67% -35.71% -28.21% -33.9% -23.38% -23.0% -63.24% -14.47% -33.61% -51.57% 46.95% 23.71% 42.78% 66.38% 151.65% 175.76% 73.68% 46.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $187.7M $133.7M $221.3M $222.3M $133.7M $99.20M $134.4M $32.00M $35.20M $0.00 $3.500M $19.80M $900.0K $11.20M $1.300M $11.40M $16.20M $35.50M $45.30M $40.00M $19.30M $20.70M $14.80M $300.0K $0.00 $0.00 $0.00 $0.00
YoY Change 40.43% -39.59% -0.47% 66.27% 34.78% -26.19% 320.0% -9.09% -82.32% 2100.0% -91.96% 761.54% -88.6% -29.63% -54.37% -21.63% 13.25% 107.25% -6.76% 39.86% 4833.33%
Other Assets $1.139B $564.0M $535.6M $62.80M $55.60M $23.60M $11.10M $18.70M $43.80M $35.10M $29.40M $8.500M $3.500M $18.90M $37.20M $0.00 $0.00 $2.100M $5.900M $18.20M $17.00M $11.30M $6.900M $3.300M $500.0K $100.0K $100.0K $0.00 $0.00
YoY Change 101.87% 5.31% 752.86% 12.95% 135.59% 112.61% -40.64% -57.31% 24.79% 19.39% 245.88% 142.86% -81.48% -49.19% -100.0% -64.41% -67.58% 7.06% 50.44% 63.77% 109.09% 560.0% 400.0% 0.0%
Total Long-Term Assets $2.383B $1.748B $1.815B $1.201B $945.3M $813.5M $797.7M $644.4M $165.0M $116.9M $73.80M $20.90M $18.20M $34.10M $56.30M $26.90M $11.30M $25.80M $20.10M $35.60M $68.60M $93.30M $114.4M $238.9M $112.4M $98.90M $56.20M $23.70M $9.200M $3.400M $1.900M $1.300M
YoY Change 36.29% -3.67% 51.1% 27.05% 16.2% 1.98% 23.79% 290.55% 41.15% 58.4% 253.11% 14.84% -46.63% -39.43% 109.29% 138.05% -56.2% 28.36% -43.54% -48.1% -26.47% -18.44% -52.11% 112.54% 13.65% 75.98% 137.13% 157.61% 170.59% 78.95% 46.15%
Total Assets $6.782B $5.841B $4.933B $3.561B $3.427B $2.646B $2.303B $1.639B $1.007B $796.5M $629.6M $330.4M $329.0M $489.6M $712.4M $232.4M $275.7M $353.6M $374.1M $516.9M $379.5M $552.1M $705.6M $886.8M $221.9M $230.3M $199.1M $66.90M $58.80M $28.70M $17.60M $6.800M
YoY Change
Accounts Payable $1.348B $277.5M $172.1M $98.80M $83.60M $103.8M $67.70M $75.60M $30.10M $24.50M $19.10M $14.00M $14.90M $10.80M $21.00M $15.70M $7.800M $5.900M $3.600M $2.300M $6.500M $9.100M $7.300M $17.50M $6.500M $8.200M $5.800M $4.700M $2.300M $1.500M $500.0K $100.0K
YoY Change 385.57% 61.26% 74.2% 18.18% -19.46% 53.32% -10.45% 151.16% 22.86% 28.27% 36.43% -6.04% 37.96% -48.57% 33.76% 101.28% 32.2% 63.89% 56.52% -64.62% -28.57% 24.66% -58.29% 169.23% -20.73% 41.38% 23.4% 104.35% 53.33% 200.0% 400.0%
Accrued Expenses $735.7M $575.6M $460.3M $370.7M $274.7M $191.6M $216.0M $178.4M $125.4M $98.50M $76.10M $56.00M $51.40M $35.80M $44.80M $34.60M $28.10M $20.50M $23.70M $24.80M $29.10M $56.00M $49.70M $35.60M $18.50M $12.60M $8.600M $1.600M $900.0K $300.0K $200.0K $0.00
YoY Change 27.8% 25.07% 24.16% 34.95% 43.37% -11.3% 21.08% 42.26% 27.31% 29.43% 35.89% 8.95% 43.58% -20.09% 29.48% 23.13% 37.07% -13.5% -4.44% -14.78% -48.04% 12.68% 39.61% 92.43% 46.83% 46.51% 437.5% 77.78% 200.0% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $32.60M $3.179M $2.635M $2.300M $19.00M $18.70M $7.400M $0.00 $85.20M $0.00 $100.0K $100.0K $300.0K $200.0K
YoY Change 925.51% 20.65% 14.57% -87.89% 1.6% 152.7% -100.0% -100.0% 0.0% -66.67% 50.0%
Total Short-Term Liabilities $1.380B $1.157B $854.3M $631.2M $513.3M $425.3M $375.4M $273.5M $168.0M $221.1M $108.0M $136.1M $135.6M $113.6M $132.8M $50.30M $36.60M $49.30M $27.90M $31.50M $42.00M $77.70M $86.10M $76.30M $51.50M $49.90M $52.20M $21.10M $10.60M $4.600M $1.000M $600.0K
YoY Change 19.29% 35.44% 35.35% 22.97% 20.69% 13.29% 37.26% 62.8% -24.02% 104.72% -20.65% 0.37% 19.37% -14.46% 164.02% 37.43% -25.76% 76.7% -11.43% -25.0% -45.95% -9.76% 12.84% 48.16% 3.21% -4.41% 147.39% 99.06% 130.43% 360.0% 66.67%
Long-Term Debt $29.16M $30.08M $31.63M $32.60M $31.90M $17.40M $16.60M $651.5M $619.9M $590.0M $681.5M $331.1M $316.2M $293.4M $443.1M $396.2M $386.6M $371.1M $341.9M $378.8M $167.8M $172.0M $179.2M $187.8M $200.0K $800.0K $1.200M $0.00 $100.0K $100.0K $500.0K $400.0K
YoY Change -3.06% -4.9% -2.97% 2.19% 83.33% 4.82% -97.45% 5.1% 5.07% -13.43% 105.83% 4.71% 7.77% -33.78% 11.84% 2.48% 4.18% 8.54% -9.74% 125.74% -2.44% -4.02% -4.58% 93800.0% -75.0% -33.33% -100.0% 0.0% -80.0% 25.0%
Other Long-Term Liabilities $212.0M $283.7M $277.4M $285.9M $283.1M $277.1M $279.9M $294.1M $48.40M $67.10M $32.30M $38.20M $104.3M $171.2M $238.8M $6.600M $12.10M $18.10M $23.80M $28.20M $15.40M $500.0K $500.0K $0.00 $0.00 $0.00
YoY Change -25.27% 2.27% -2.97% 0.99% 2.17% -1.0% -4.83% 507.64% -27.87% 107.74% -15.45% -63.37% -39.08% -28.31% 3518.18% -45.45% -33.15% -23.95% -15.6% 83.12% 0.0%
Total Long-Term Liabilities $212.0M $313.8M $309.0M $318.5M $315.0M $294.5M $296.5M $945.6M $668.3M $657.1M $713.8M $369.3M $420.5M $464.6M $681.9M $402.8M $398.7M $389.2M $365.7M $407.0M $183.2M $172.0M $179.2M $187.8M $200.0K $800.0K $1.200M $500.0K $600.0K $100.0K $500.0K $400.0K
YoY Change -32.44% 1.54% -2.97% 1.11% 6.96% -0.67% -68.64% 41.49% 1.7% -7.94% 93.28% -12.18% -9.49% -31.87% 69.29% 1.03% 2.44% 6.43% -10.15% 122.16% 6.51% -4.02% -4.58% 93800.0% -75.0% -33.33% 140.0% -16.67% 500.0% -80.0% 25.0%
Total Liabilities $1.592B $1.471B $1.163B $949.7M $828.3M $719.8M $672.0M $1.219B $836.3M $878.1M $822.7M $505.4M $556.0M $578.2M $814.8M $453.1M $435.2M $438.5M $393.5M $438.4M $225.2M $249.7M $265.4M $264.1M $51.70M $50.70M $53.40M $21.60M $11.30M $4.700M $1.500M $1.000M
YoY Change 8.25% 26.43% 22.5% 14.66% 15.07% 7.11% -44.88% 45.77% -4.76% 6.73% 62.78% -9.1% -3.84% -29.04% 79.83% 4.11% -0.75% 11.44% -10.24% 94.67% -9.81% -5.92% 0.49% 410.83% 1.97% -5.06% 147.22% 91.15% 140.43% 213.33% 50.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992
Basic Shares Outstanding 223.6M shares 222.0M shares 220.4M 218.1M 214.9M 212.4M 204.6M
Diluted Shares Outstanding 225.9M shares 224.0M shares 222.1M 218.1M 217.7M 215.6M 204.6M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $14.376 Billion

About INCYTE CORP

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. The company is headquartered in Wilmington, Delaware and currently employs 2,524 full-time employees. The firm operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib), ICLUSIG (ponatinib), and ZYNYZ (retifanlimab-dlwr), as well as numerous clinical development programs. The firm's pipeline also includes two first-in-class small molecule antagonists targeting Mas-related G protein-coupled receptor X2 (MRGPRX2) for the treatment of various mast cell mediated disorders and MRGPRX4 for cholestatic pruritus.

Industry: Services-Commercial Physical & Biological Research Peers: ALNYLAM PHARMACEUTICALS, INC. Sarepta Therapeutics, Inc. BIOGEN INC. Biohaven Pharmaceutical Holding Co Ltd. BIOMARIN PHARMACEUTICAL INC Moderna, Inc. NEUROCRINE BIOSCIENCES INC Seagen Inc. UNITED THERAPEUTICS Corp